SAGCN: Using Graph Convolutional Network With Subgraph-Aware for circRNA-Drug Sensitivity Identification

Insights

This study introduces SAGCN, a computational method for predicting circular RNA-drug sensitivity associations (CDA). SAGCN accurately identifies these crucial links, aiding cancer therapy and drug discovery.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Circular RNAs (circRNAs) are implicated in cancer development and drug resistance.
  • circRNA expression significantly influences cellular drug sensitivity.
  • Identifying circRNA-drug sensitivity associations (CDA) is vital for advancing cancer treatment and drug discovery.

Purpose of the Study:

  • To address the time-consuming and costly nature of experimental CDA identification.
  • To develop an efficient computational method for predicting CDA.
  • To propose the subgraph-aware graph convolutional network (SAGCN) for CDA prediction.

Main Methods:

  • Constructed a heterogeneous network integrating circRNA similarity, drug similarity, and circRNA-drug bipartite networks.
  • Employed a subgraph extractor utilizing graph convolutional networks to learn latent network structures.
  • Integrated 1-hop and 2-hop information using a fusing attention mechanism and a novel subgraph-aware attention mechanism.

Main Results:

  • The SAGCN model achieved an average AUC of 0.9120 and AUPR of 0.8693.
  • SAGCN outperformed existing state-of-the-art models in 10-fold cross-validation.
  • Case studies validated SAGCN's capability in identifying circRNA-drug sensitivity links.

Conclusions:

  • SAGCN provides an effective computational approach for predicting circRNA-drug sensitivity associations.
  • The method offers a valuable tool for accelerating drug discovery and optimizing cancer therapies.
  • SAGCN's performance highlights the potential of graph-based deep learning in biological network analysis.